These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7180471)

  • 21. [Screening for the new formulation of 25% ascorbic acid injection and studies on its stability].
    Guo Y; Chen X; Zhao Y; Sun J
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):327-31. PubMed ID: 9389075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Photosensitivity of aqueous solutions of methotrexate and ascorbic acid].
    Battelli G; Marra M; Romagnoli E; Tagliapietra L; Tassara A
    Boll Chim Farm; 1983 Mar; 122(3):149-57. PubMed ID: 6680323
    [No Abstract]   [Full Text] [Related]  

  • 23. Stability of sodium 5,6-benzylidene-L-ascorbate.
    Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
    Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stabilization of solutions for injections with ascorbic acid].
    BREIGINA KhS; BARTASHEVICH OA
    Aptechn Delo; 1954; 3(4):12-4. PubMed ID: 13189364
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the formulation and admixture of parenteral preparations. I. Degradation of ascorbic acid and cyanocobalamin by sodium bisulfite added to ascorbic acid injection (author's transl)].
    Terao M; Marui E; Tanaka K; Nakao Y
    Yakugaku Zasshi; 1980 Jan; 100(1):81-7. PubMed ID: 7373525
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydrophilic interaction liquid chromatography method for the determination of ascorbic acid.
    Nováková L; Solichová D; Pavlovicová S; Solich P
    J Sep Sci; 2008 May; 31(9):1634-44. PubMed ID: 18428189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of the stability of eyedrops with riboflavin and ascorbic acid].
    Parnovs'kiĭ BL; Gladyshevskaia-Veselovska ; Krivtsov IuB
    Farm Zh; 1971; 26(3):32-4. PubMed ID: 5122720
    [No Abstract]   [Full Text] [Related]  

  • 28. An immunohistological study of anhydrous topical ascorbic acid compositions on ex vivo human skin.
    Heber GK; Markovic B; Hayes A
    J Cosmet Dermatol; 2006 Jun; 5(2):150-6. PubMed ID: 17173590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of ascorbic acid in nanolitre samples by means of capillary batch injection analysis.
    Backofen U; Matysik FM; Hoffmann W; Ache HJ
    Biomed Chromatogr; 1998; 12(3):145-6. PubMed ID: 9646917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on foods fortified with L-ascorbic acid derivatives. I. Preparation and properties of L-ascorbic phosphate (author's transl)].
    Tao GQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jan; 15(1):30-3. PubMed ID: 7307800
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of ascorbic acid on penicillin-induced epileptiform activity in rats.
    Ayyildiz M; Coskun S; Yildirim M; Agar E
    Epilepsia; 2007 Jul; 48(7):1388-95. PubMed ID: 17433052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of fluconazole in injectable solutions.
    Hunt-Fugate AK; Hennessey CK; Kazarian CM
    Am J Hosp Pharm; 1993 Jun; 50(6):1186-7. PubMed ID: 8517459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Decomposition rate of ascorbic acid in the presence and in the absence of oxygen].
    Krówczyński L; Krasowska H; Makosz A
    Acta Pol Pharm; 1966; 23(6):493-8. PubMed ID: 5960079
    [No Abstract]   [Full Text] [Related]  

  • 34. Stability of ascorbic acid in serum and plasma prior to analysis.
    Ching SY; Prins AW; Beilby JP
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):518-20. PubMed ID: 12227861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice.
    Sahraei H; Aliabadi AA; Zarrindast MR; Ghoshooni H; Nasiri A; Barzegari-Sorkheh AA; Yari M; Zardooz H; Hossein-Mardi L; Faraji N; Shams J
    Eur J Pharmacol; 2007 Mar; 560(1):42-8. PubMed ID: 17292882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of direct compression excipients on the stability of ascorbic acid (vitamin c) tablets.
    Ofoefule SI; Chukwube VO; Attama AA
    Boll Chim Farm; 1999 Sep; 138(8):418-21. PubMed ID: 10622107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of captopril in three liquid dosage forms.
    Nahata MC; Morosco RS; Hipple TF
    Am J Hosp Pharm; 1994 Jan; 51(1):95-6. PubMed ID: 8135269
    [No Abstract]   [Full Text] [Related]  

  • 38. Antioxidant and pro-oxidant assay for a new drug GEPC: detected by ESR spectrometry and by protective effects on lipid peroxidation and biomolecule degradation.
    Liu J; Mori A; Ogata K
    Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):151-66. PubMed ID: 8303085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug decomposition kinetics. LXX. Stability of ascorbic acid in Asconerin and Glucovit].
    Pawełczyk E; Zajac M
    Acta Pol Pharm; 1982; 39(4):221-6. PubMed ID: 7164832
    [No Abstract]   [Full Text] [Related]  

  • 40. [The laser-magnetic phoresis of ascorbic acid in the combined health-resort therapy of osteoarthrosis patients].
    Ibadova GD; Khamrakulova VV; Lopatinskiĭ VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (4):17-9. PubMed ID: 8975469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.